Home LiteratureArticle Details
PMID: 6781220 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A simple method for the production of F(ab')2 preparations by pepsin digestion of total serum protein.

Acta pathologica et microbiologica Scandinavica. Section C, Immunology ·Vol. 88 ·No. 5 ·1980-10-00 ·Pages 241-5

Poulsen F, Hjort T

Abstract

An easy and rapid method for producing F(ab')2 fragments by pepsin treatment of total serum protein is described. No further purification of the hydrolysate was used. Most serum proteins were degraded to small peptides which were removed by dialysis, the preparations thus being relatively rich in F(ab')2 fragments. The degree of hydrolysis was determined by means of an antiserum against the part of the gamma-chain which is degraded by pepsin. Under optimal conditions for hydrolysis, unsplit IgG could not be detected by double immunodiffusion. Using sperm-agglutinating and immobilizing sera, the F(ab')2 preparations could be characterized functionally. After hydrolysis the agglutinating activity was relatively unchanged, whereas the immobilizing activity had vanished.

MeSH Terms
Blood Proteins/metabolism Chemical Precipitation Chromatography, Gel Humans Hydrolysis Immunodiffusion Immunoelectrophoresis Immunoglobulin Fab Fragments/biosynthesis Male Methods Pepsin A/pharmacology
Chemicals
Blood Proteins Immunoglobulin Fab Fragments Pepsin A
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Poulsen F
Hjort T
Article Info
Journal
Acta pathologica et microbiologica Scandinavica. Section C, Immunology
Abbr.
Acta Pathol Microbiol Scand C
ISSN
0304-1328
Published
1980-10-00
Pages
241-5
Language
English
Region
Denmark
NLM ID
7508469
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com